NIA Clinical Trails Operations Support Center
ID: 75N95024R00017Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

PSC

SUPPORT- MANAGEMENT: OTHER (R799)

Original Source

https://sam.gov/opp/5e0a63cf23954a98ba32fb8742d9cbc7/view
Timeline
    Description

    Special Notice HEALTH AND HUMAN SERVICES, DEPARTMENT OF NIA Clinical Trails Operations Support Center

    The National Institute on Drug Abuse (NIDA), Office of Acquisition, on behalf of the National Institute on Aging (NIA), intends to negotiate and award a modification to the NIA Clinical Trials Operations Support Center. The objective of this modification is to continue the operation of the CTOSC in order to provide support for the management, tracking, and oversight of clinical trials funded by the NIA. The contractor will provide technical and administrative assistance to investigators in the areas of quality assurance and safety. The contractor will also provide scientific resources and services necessary to support a broad range of activities required to effectively manage the NIA clinical trials. The period of performance for the contract ends on January 1, 2024, and this modification would extend the period of performance by three months with four one-month options, potentially through August 1, 2024. The intended procurement is classified under NAICS code 541990 – All other Professional, Scientific and Technical Services with a Size Standard of $17.0 million. This acquisition is conducted as non-competitive under the authority of 41 U.S.C. 3304(a) under provisions of the statutory authority of FAR Subpart 6.302-1 -- Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. The contractor shall provide all necessary services, qualified personnel, material, equipment, and facilities to serve as a Clinical Trials Operations Support Center. The contractor shall provide support in project management, clinical trials operations, quality assurance, safety-related operations, statistical and methodological consultation, training of NIA staff, maintenance of the NIA database, and transition plan and contract closeout. The contract type is Cost-Plus-Fixed-Fee. This modification is necessary to ensure continuing operations support for NIA-funded clinical trials while the NIA completes a new acquisition that will include the tasks of this contract along with other requirements. Interested parties may identify their interest and capability to respond to this notice. All responses must be received by Friday, December 1, 2023, at 11:00 AM Eastern Time and must reference number 75N95024R00017.

    Point(s) of Contact
    Hashim Dasti
    hashim.dasti@nih.gov
    Karen Mahon
    Karen.Mahon@nih.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    NIA Clinical Trails Operations Support Center
    Currently viewing
    Special Notice
    Similar Opportunities
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for the NIAID Clinical Products Center (CPC) contract, aimed at supporting clinical trials focused on immunologic, infectious, and allergic diseases. The contract will provide essential pharmacy and pharmaceutical oversight for national and international clinical trials, ensuring product integrity, participant safety, and compliance with regulatory standards, while also expanding support for additional NIH-funded trials and emergency public health programs as needed. This initiative is critical for advancing research in various immune-mediated diseases, including asthma, autoimmune disorders, and organ transplant rejection. Interested parties should prepare to submit proposals electronically via the NIAID electronic Contract Proposal Submission (eCPS) website, with the presolicitation notice expected to be published on or around October 18, 2024. For further inquiries, contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov.
    PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute on Drug Abuse (NIDA), is seeking proposals for the "Preparation and Distribution of Research Drug Products" under Request for Proposal (RFP) No. 75N95024R00003. The primary objective of this procurement is to acquire, analyze, create, regulate, and distribute a variety of drug compounds essential for advancing research on drug abuse and addiction, including controlled and uncontrolled substances such as morphine, methadone, and various cannabinoid preparations. This contract, structured as an indefinite delivery, indefinite quantity (IDIQ) agreement for a five-year period, is crucial for supporting the drug abuse research community by ensuring the availability of authentic drug products while adhering to federal regulations. Proposals must be submitted electronically by November 15, 2024, and interested parties can contact Scott Duernberger at scott.duernberger@nih.gov or Josh Lazarus at josh.lazarus@nih.gov for further information.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Chemistry, Manufacturing, and Controls (CMC) services related to the development of drug substances, as outlined in RFP Number 75N95024R00094. The primary objective is to ensure the provision of high-quality drug substances to support preclinical and Investigational New Drug (IND)-enabling studies, which are critical for advancing therapeutic innovations. This opportunity emphasizes compliance with current Good Manufacturing Practices (cGMP) and requires detailed reporting and documentation throughout the contract period. Interested contractors should note that the proposal submission deadline is December 3, 2024, with a maximum funding amount of $49.7 million anticipated for the contract period from September 1, 2025, to May 14, 2031. For further inquiries, potential bidders can contact Samson Shifaraw at samson.shifaraw@nih.gov or Valerie Whipple at valerie.whipple@nih.gov.
    Notice of Intent for Meso Scale Discovery Sector S 600 Readers Service Contract
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source maintenance service contract with Meso Scale Diagnostics LLC for the servicing of MESO SECTOR S 600MM instruments located at its Gaithersburg, MD facility. The contract encompasses several service packages, including preventive maintenance inspections, repairs, and pre-contract inspections for specific instruments, with maintenance services set to commence between October 24, 2024, and April 17, 2025, and concluding on May 5, 2025. This procurement is critical for ensuring the operational reliability of laboratory equipment essential for research, and it mandates that vendors provide factory-trained technicians and OEM specification parts. Interested vendors must submit their capability statements and relevant documentation via the NIAID electronic Simplified Acquisition Submission System (eSASS) by 10:00 AM on October 18, 2024, as this opportunity is not a request for proposals.
    Maintenance and Repair Service for a 3730XL DNA Analyzer
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking proposals for maintenance and repair services for a 3730XL DNA Analyzer, a critical piece of equipment used in ongoing research at the National Institute on Aging (NIA). The contract will cover comprehensive maintenance services, including preventative maintenance, software upgrades, and troubleshooting support, ensuring the equipment remains fully operational to support vital research activities. The anticipated contract spans a base year from November 16, 2024, with four optional renewal years, and proposals must be submitted by October 22, 2024, to Rashiid Cummins at rashiid.cummins@nih.gov. This procurement is non-competitive and is expected to be awarded to Life Technologies Corporation, the manufacturer of the analyzer.
    J--NIAAA: Service: Maintenance Agreement
    Active
    Health And Human Services, Department Of
    The National Institute on Alcohol Abuse and Alcoholism (NIAAA) plans to award a non-competitive purchase order for a maintenance agreement on Ion Proton Sequencing Systems to Life Technologies Corporation. This agreement is essential for ensuring the systems' optimal performance through preventative maintenance, emergency repairs, and necessary updates, which are critical for ongoing genetic analyses related to mental health and alcohol use disorder research. Life Technologies is uniquely positioned to fulfill this requirement due to its proprietary access to technical resources and factory-trained engineers, making it the sole source for this maintenance service. Interested parties may express their capability to respond to this notice by October 22, 2024, although this is not a competitive proposal request, and the contract period is set from November 22, 2024, to November 21, 2025. For further inquiries, contact Nicole T. Freid at nicole.freid@nih.gov or +1 301 480 6914.
    Scientific Management and Support to the National Institute of Mental Health (NIMH) Repository and Genomics Resource (NRGR)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for scientific management and support services for the National Institute of Mental Health Repository and Genomics Resource (NRGR). The objective of this procurement is to sustain, enhance, and enrich the NRGR, which provides critical biospecimens and genomic data for research on psychiatric disorders, thereby facilitating a deeper understanding of the genetic factors associated with mental health. This initiative is vital for advancing research in the genetics of mental disorders and ensuring broad access to valuable biospecimens and data resources for the scientific community. Proposals are due by November 8, 2024, and must be submitted electronically via the NIH's eCPS system; interested parties should contact Sarah Adan at sarah.adan@nih.gov or Valerie Whipple at valerie.whipple@nih.gov for further information.
    A--BPCA Pediatric Trials Network
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for the Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN) under solicitation number 75N94024R00008. The objective of this procurement is to establish an Indefinite Quantity Contract for the creation, operation, and maintenance of an infrastructure dedicated to conducting pediatric clinical trials, with a performance period extending from May 19, 2025, to May 18, 2033. This initiative is crucial for advancing pediatric drug development and ensuring compliance with ethical standards in clinical research. Interested parties must submit their proposals by November 4, 2024, with a potential contract value ranging from a minimum of $2,500 to a maximum of $149 million, contingent on successful performance. For further inquiries, contact Elizabeth J. Osinski at eo43m@nih.gov or call 240-550-5028.
    Notice of Intent to Sole Source; Harris OnPoint
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Harris OnPoint Solutions for the provision of technical services related to the AcuityPlus software at the NIH Clinical Center in Bethesda, Maryland. The acquisition aims to ensure annual maintenance and support for the AcuityPlus system, which is critical for enhancing productivity and identifying best practices by comparing acuity data across organizations. As Harris OnPoint is the sole manufacturer and licenser of the AcuityPlus system, no new training is required for the nursing staff already utilizing the software. Interested parties may express their interest and capabilities to Kristin Nagashima at kristin.nagashima@nih.gov by October 31, 2024, at 1 PM EST.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Center for Advancing Translational Sciences (NCATS), is seeking qualified small businesses to provide Chemistry, Manufacturing, and Controls (CMC) and related services for the development of drug products. The objective of this procurement is to support the Therapeutic Development Branch in ensuring the delivery of drug products of sufficient quality and quantity for preclinical, IND-enabling, and clinical studies, which are critical for advancing therapeutic candidates through the drug development pipeline. This opportunity is part of a Small Business Sources Sought notice, aimed at gathering information on the capabilities of small businesses to fulfill these requirements, with a focus on compliance with applicable regulations and the potential for a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract. Interested vendors must submit their capability statements by 10:00 AM Eastern Time on July 21, 2024, to Michelle Cecilia at michelle.cecilia@nih.gov.